Winton Matthew 4
4 · Inozyme Pharma, Inc. · Filed Apr 4, 2023
Insider Transaction Report
Form 4
Transactions
- Award
Stock option (right to buy)
2023-04-03+250,000→ 250,000 totalExercise: $5.39Exp: 2033-04-02→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The option was granted on April 3, 2023 and is scheduled to vest 25% on the first anniversary of the grant date. The remainder of the shares underlying the option are scheduled to vest in equal monthly installments over the following three years until the fourth anniversary of the grant date.